 Secondary efficacy measures will include changes from baseline in mean weekly sleep interference scores, Short-Form McGill Pain Questionnaire SF-MPQ, the Neuropathic Pain Scale NPS, Brief Pain Inventory BPI, Patient Global Impression of Change PGIC, and Investigator-Rated Clinical Global Impression of Change CGIC. 